Predictors of future overdose among people who inject drugs in Baltimore, Maryland
Identifying and intervening with PWID who experienced a recent overdose could reduce short-term elevated risk of future overdose. However, as other PWID reported never experiencing an overdose at baseline nonetheless experienced an overdose during follow-up, targeted approaches should be complemented with population-level interventions. Overdose risk implications of buprenorphine treatment and non-prescribed methadone are also discussed.
Authors
- Kathleen R. Page (ORCID: https://orcid.org/0000-0002-6859-1973)
- Oluwaseun O Falade-Nwulia (ORCID: https://orcid.org/0000-0003-2321-2295)
- Amanda Rosecrans (ORCID: https://orcid.org/0000-0003-3230-0684)
- Gregory M. Lucas (ORCID: https://orcid.org/0000-0002-3013-4339)
- Miles Landry (ORCID: https://orcid.org/0000-0002-1207-9954)
- Katie Zook
- Suzanne M. Grieb (ORCID: https://orcid.org/0000-0001-9971-4115)
- Brian W. Weir (ORCID: https://orcid.org/0000-0003-1634-218X)
- Susan G. Sherman
- Michael P. Ramirez
- Robert S. Harris
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Baltimore City Health Department (US)
Publication Details
- Journal
- Drug and Alcohol Dependence Reports
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1016/j.dadr.2024.100286
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Mental Health
- National Institute on Drug Abuse
- Office of Behavioral and Social Sciences Research